JP Morgan Chase
JBIO

JP Morgan Chase’s Jade Biosciences JBIO Stock Holding History

JP Morgan Chase’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$210K Sell
15,863
-4,736
-23% -$68.6K ﹤0.01% 5445
2025
Q4 		$318K Buy
20,599
+7,401
+56% +$86.8K ﹤0.01% 5282
2025
Q3 		$114K Sell
13,198
-2,169
-14% -$17.7K ﹤0.01% 5830
2025
Q2 		$154K Buy
15,367
+13,205
+611% +$449K ﹤0.01% 5379
2025
Q1 		$190K Buy
2,162
+243
+13% +$21.3K ﹤0.01% 5263
2024
Q4 		$178K Buy
1,919
+1,748
+1,022% +$151K ﹤0.01% 5527
2024
Q3 		$12.5K Buy
171
+5
+3% +$323 ﹤0.01% 6328
2024
Q2 		$9.67K Buy
166
+35
+27% +$23.2K ﹤0.01% 6272
2024
Q1 		$136K Sell
131
-83
-39% -$63.4K ﹤0.01% 5539
2023
Q4 		$169K Buy
214
+2
+0.9% +$1.02K ﹤0.01% 5483
2023
Q3 		$101K Sell
212
-19
-8% -$10.3K ﹤0.01% 5466
2023
Q2 		$138K Buy
231
+29
+14% +$18.5K ﹤0.01% 5296
2023
Q1 		$143K Buy
202
+52
+35% +$43.1K ﹤0.01% 5260
2022
Q4 		$154K Sell
150
-45
-23% -$32.7K ﹤0.01% 5165
2022
Q3 		$113K Buy
195
+27
+16% +$18K ﹤0.01% 5230
2022
Q2 		$92K Sell
168
-89
-35% -$42.5K ﹤0.01% 5450
2022
Q1 		$165K Buy
257
+85
+49% +$33K ﹤0.01% 5287
2021
Q4 		$71K Buy
172
+22
+15% +$11.1K ﹤0.01% 5813
2021
Q3 		$110K Buy
+150
New +$84K ﹤0.01% 5518

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

JP Morgan Chase's JBIO Position: Q1 2026 in Review

JP Morgan Chase reduced its Jade Biosciences (JBIO) stake by 23% in Q1 2026, selling an estimated $68.6K and leaving 15,863 shares worth $210K. The position accounts for ﹤0.01% of the portfolio, ranked #5445.

JP Morgan Chase first reported a position in JBIO in Q3 2021 and has held it in 19 quarters since. The position peaked at $318K in Q4 2025. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

  • JP Morgan Chase held 15,863 shares of Jade Biosciences worth $210K as of Q1 2026.
  • JP Morgan Chase sold 4,736 Jade Biosciences shares in Q1 2026, an estimated $68.6K.
  • Jade Biosciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5445 holding.
  • JP Morgan Chase first reported a position in Jade Biosciences in Q3 2021 and has held it in 19 quarters since.
  • JP Morgan Chase's Jade Biosciences position peaked at $318K in Q4 2025.
  • 120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.